Target Price | €35.75 |
Price | €26.03 |
Potential | 37.32% |
Number of Estimates | 20 |
20 Analysts have issued a price target Vonovia 2026 . The average Vonovia target price is €35.75. This is 37.32% higher than the current stock price. The highest price target is €45.80 75.95% , the lowest is €26.80 2.96% . | |
A rating was issued by 21 analysts: 14 Analysts recommend Vonovia to buy, 4 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Vonovia stock has an average upside potential 2026 of 37.32% . Most analysts recommend the Vonovia stock at Purchase. |
12 Analysts have issued a sales forecast Vonovia 2024 . The average Vonovia sales estimate is €3.1b . This is 50.69% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €3.5b 44.76% , the lowest is €2.4b 62.07% .
This results in the following potential growth metrics:
2023 | €4.9b | 0.33% |
---|---|---|
2024 | €3.1b | 36.45% |
2025 | €3.2b | 2.26% |
2026 | €3.3b | 4.13% |
2027 | €4.1b | 23.45% |
2028 | €3.9b | 4.56% |
17 Analysts have issued an Vonovia EBITDA forecast 2024. The average Vonovia EBITDA estimate is €2.6b . This is 7.38% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €2.9b 20.32% , the lowest is €2.3b 6.95% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €2.2b | 3.18% |
---|---|---|
2024 | €2.6b | 20.93% |
2025 | €2.9b | 9.09% |
2026 | €3.0b | 5.67% |
2027 | €3.6b | 17.43% |
2028 | €4.5b | 27.38% |
2023 | 44.10% | 3.51% |
---|---|---|
2024 | 83.92% | 90.29% |
2025 | 89.52% | 6.67% |
2026 | 90.84% | 1.47% |
2027 | 86.41% | 4.88% |
2028 | 115.32% | 33.46% |
6 Vonovia Analysts have issued a net profit forecast 2024. The average Vonovia net profit estimate is €-442m . This is 86.79% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €-191m 94.31% , the lowest is €-1.2b 65.36% .
This results in the following potential growth metrics and future Net Margins:
2023 | €-6.4b | 851.22% |
---|---|---|
2024 | €-442m | 93.11% |
2025 | €2.1b | 571.73% |
2026 | €2.9b | 39.17% |
2027 | €5.4b | 86.86% |
2023 | -130.21% | 854.35% |
---|---|---|
2024 | -14.12% | 89.16% |
2025 | 65.13% | 561.26% |
2026 | 87.05% | 33.66% |
2027 | 131.77% | 51.37% |
6 Analysts have issued a Vonovia forecast for earnings per share. The average Vonovia <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €-0.54 . This is 86.73% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €-0.23 94.35% , the lowest is €-1.41 65.36% .
This results in the following potential growth metrics and future valuations:
2023 | €-7.80 | 851.22% |
---|---|---|
2024 | €-0.54 | 93.08% |
2025 | €2.54 | 570.37% |
2026 | €3.53 | 38.98% |
2027 | €6.59 | 86.69% |
Current | -6.40 | 84.44% |
---|---|---|
2024 | -48.42 | 656.56% |
2025 | 10.27 | 121.21% |
2026 | 7.38 | 28.14% |
2027 | 3.95 | 46.48% |
Based on analysts' sales estimates for 2024, the Vonovia stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 21.46 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 6.84 .
This results in the following potential growth metrics and future valuations:
Current | 10.58 | 1.44% |
---|---|---|
2024 | 21.46 | 102.80% |
2025 | 20.98 | 2.21% |
2026 | 20.15 | 3.96% |
2027 | 16.32 | 19.00% |
2028 | 17.10 | 4.78% |
Current | 3.37 | 1.82% |
---|---|---|
2024 | 6.84 | 102.82% |
2025 | 6.69 | 2.22% |
2026 | 6.42 | 3.96% |
2027 | 5.20 | 19.00% |
2028 | 5.45 | 4.78% |
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Buy
➜
Buy
|
Unchanged | Jan 06 2025 |
METZLER EQUITIES |
Sell
➜
Sell
|
Unchanged | Jan 03 2025 |
BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Jan 02 2025 |
ODDO BHF |
Buy
➜
Buy
|
Unchanged | Dec 15 2024 |
WARBURG RESEARCH GMBH |
Buy
➜
Buy
|
Unchanged | Nov 26 2024 |
ING FM |
Buy
➜
Buy
|
Unchanged | Nov 26 2024 |
HSBC |
Buy
➜
Buy
|
Unchanged | Nov 24 2024 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Jan 06 2025 |
Unchanged
METZLER EQUITIES:
Sell
➜
Sell
|
Jan 03 2025 |
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Jan 02 2025 |
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Dec 15 2024 |
Unchanged
WARBURG RESEARCH GMBH:
Buy
➜
Buy
|
Nov 26 2024 |
Unchanged
ING FM:
Buy
➜
Buy
|
Nov 26 2024 |
Unchanged
HSBC:
Buy
➜
Buy
|
Nov 24 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.